There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

All these years I thought that thin people — those people — just had more willpower,” Winfrey said on her podcast.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

In a discussion with Oprah, Dr Ania called obesity a disease. She also advised that we should treat obesity like other ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

On her latest podcast episode, Oprah Winfrey shared how weight loss medication helped her see the truth behind thin people's eating habits, debunking her previous beliefs about willpower and food ...